The Patent Finder

Isolation, Detection, Diagnosis And/Or Characterization of Circulating TROP-2-Positive Cancer Cells

Immunomedics, Inc.

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 2 of these applications claim priority to application 62/151,169, filed Apr 22, 2015. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 9,797,907Isolation, Detection, Diagnosis And/Or Characterization of Circulating TROP-2-Positive Cancer Cells
In force
 · High confidence
UsedRemaining
Immunomedics, Inc.In forceHigh confidence
US 10,436,788Isolation, Detection, Diagnosis And/Or Characterization of Circulating TROP-2-Positive Cancer Cells
In force
 · High confidence
Immunomedics, Inc.In forceHigh confidence
Application 16/548,445Isolation, Detection, Diagnosis And/Or Characterization of Circulating TROP-2-Positive Cancer Cells
Abandoned
Abandoned Oct 1, 2022
Immunomedics, Inc.AbandonedAbandoned Oct 1, 2022
3 of 3 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
2 of these are in force and held by Immunomedics, Inc..
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited